BLUE
bluebird bio
BLUE
BLUE
Delisted
BLUE was delisted on the 30th of May, 2025.
81 hedge funds and large institutions have $378M invested in bluebird bio in 2013 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 32 increasing their positions, 16 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
Holders
81
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
1 | +$41.9M | |
2 | +$33.2M | |
3 | +$10.1M | |
4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$5.64M |
5 |
FAM
Fred Alger Management
New York
|
+$4.98M |
Top Sellers
1 | -$6M | |
2 | -$2.56M | |
3 | -$2.1M | |
4 |
QF
QVT Financial
New York
|
-$2.02M |
5 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$876K |